deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01516515

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Patients With Actinic Keratosis (AK)

Sponsor: G&E Herbal Biotechnology Co., LTD

Conditions Actinic Keratosis
Interventions SR-T100 with 2.3% of SM Vehicle gel
Updated 12 times since 2017 Last updated: Dec 3, 2018 Started: Feb 28, 2013 Primary completion: Dec 31, 2017 Completion: Oct 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Actinic Keratosis and is currently completed. G&E Herbal Biotechnology Co., LTD leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotRecruiting~Jun 2017 – ~Oct 2017 · 4 months · monthly snapshotActive Not Recruiting~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshotActive Not Recruiting~Dec 2017 – ~Mar 2018 · 3 months · monthly snapshotActive Not Recruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotActive Not Recruiting~Sep 2018 – ~Jan 2019 · 4 months · monthly snapshotActive Not Recruiting~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Sep 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE2

▶ Show 7 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE2

  2. Mar 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  3. Dec 2017 — Mar 2018 [monthly]

    Active Not Recruiting PHASE2

  4. Oct 2017 — Dec 2017 [monthly]

    Active Not Recruiting PHASE2

  5. Jun 2017 — Oct 2017 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • G&E Herbal Biotechnology Co., LTD
Data source: G&E Herbal Biotechnology Co., LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations